- Lobbying
- Lobbying by BeiGene USA, Inc.
Lobbying Relationship
Bills mentioned
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Susan Hirschmann | COS, Rep. Van Hilleary and Majority Whip Tom DeLay |
Jeanne Haggerty | Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member |
Alec Aramanda | Prof Staff, House Cmtee on E&C; Dir Ofc of Legislation & Dir Stakeholder Engagement, Centers for Medicare & Medicaid Services; Deputy Assistant Secretary for Health Policy, Department of Health & Human Services; Domestic Policy Advisor, Deputy Legislative Director, Leg Asst, Sen. Cruz; Leg Asst, Sen. DeMint. |
Matthew Hoekstra | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Medicare
Manufacturing
Registration
Issue(s) they said they’d lobby about: Issues related to drug pricing and reimbursement for prescription drugs related to H.R. 5376 - Build Back Better Act, Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate